Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. Extensive evidence has underlined the importance of mucosal healing, defined as the resolution of visible inflammation and ulceration at endoscopy, as a treatment aim for UC, and it represents the gold standard for assessing disease activity . Currently, both endoscopic Mayo scores 0 (normal mucosa) and 1 (mild erythema, decreased vascular patterns) are accepted endpoints for UC mucosal healing. We aimed to assess whether there was a difference in the incidence of clinical relapse at 12 months between UC patients with endoscopic Mayo scores 0 and 1. Methods Retrospective study, including all patients in corticosteroid-free remission between 2008 and 2013 and follow-up of at least one year with endoscopic Mayo score of 0 or 1 assessed during colonoscopy. We assessed clinical (age, gender, disease duration, therapy) as well as laboratorial values (haemoglobin, leukocytes, platelets, ferritin, CRP, ESR) at baseline colonoscopy and during a 12 month follow-up. Clinical relapse was defined as need for induction treatment, treatment escalation, hospitalization or surgery. Statistical analysis was performed with SPSS v21.0, using chi-square test and a multivariate regression model; a p value < 0,05 was considered statistically significant. Results Included 138 patients, 72 (52,2%) female, with mean age 48,9 years (SD: 13,9; range 17-78). UC was classified as proctitis in 64 (46,4%) patients, left-sided colitis in 38 (27,5%) and pancolitis in 35 (25,4%), and mean disease duration was 8 years (range 1-31). Endoscopic Mayo score was classified as 0 in 61 (44,2%) patients and 1 in 77 (55,8%) patients. Clinical relapse during follow-up occurred in 28 (20,3%) patients, and was significantly more frequent in patients with Endoscopic Mayo Score-1 (27,3 vs 11,5%; p=0,022). This association was additionally encountered in the subset of patients with left-sided colitis or pancolitis (29,7 vs 11,1%; p= 0,049), but not in patients with UC localized to the rectum (p=n.s.). In the multivariate analysis, endoscopic Mayo Score 1 was the only factor significantly associated with the risk of relapse during a 12 month follow-up (OR=2,89 CI 95% 1, 14-7,36; p=0,026). Conclusions In patients with ulcerative colitis in corticosteroid-free remission, particularly those with left sided colitis or pancolitis, endoscopic Mayo Score 1 was significantly associated with a threefold increased risk of relapse compared to endoscopic Mayo Score 0. Our results support the use of endoscopic Mayo score 0 as the most suitable treatment endpoint to define mucosal healing in patients with ulcerative colitis.
